Category Asia/Pacific

Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?

Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.

Emerging Economies’ New Initiative On Falsified And Substandard Medicines

Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.

Lack Of Transparency In EU-India FTA Talks Spurs Requests For Halt

European and Indian business not only have privileged access to information on the planned EU-India free trade agreement, they even set the agenda for this negotiation from the start. That is the conclusion of a study by the Corporate Europe Observatory (CEO) and India FDI Watch published this week in Brussels and Delhi. Both organisations intend to appeal directly to the European Commission and the Indian government to stop negotiations as long as there is no access to negotiating positions and documents for all affected parties.

The Great Firewall of China: When Does Online Censorship Violate WTO Rules?

China’s government says it is acting in the best interests of its citizens. It is regulating the internet in order to protect its people from pornography and other objectionable content. Critics, however, assert that China is guilty of wide-ranging censorship, drastically limiting what mainland residents can see, hear and say online. Moreover, according to a growing chorus, this online censorship violates World Trade Organization rules.

As WTO Reviews China, EU, US Criticise Its Policy On Innovation, IP Rights

In the past two years, China has acted to improve the protection of intellectual property rights with a need for continuing effort, a World Trade Organization report has found, but the country came under criticism this week from key trading partners such as the United States and the European Union for not providing adequate enforcement and for self-serving innovation practices.